Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.119
Neutral
RSI(14)
55.404
Neutral
STOCH(KDJ)(9,3,3)
69.628
Buy
ATR(14)
3.353
High Vlolatility
CCI(14)
182.209
Buy
Williams %R
30.491
Buy
TRIX(12,20)
0.135
Sell
StochRSI(14)
53.877
Neutral
Search
Disc Medicine Inc
IRONAdd to Watchlist
77.000USD
-2.210-2.79%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.96BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.79%
5 Days
+3.89%
1 Month
+2.74%
6 Months
-0.41%
Year to Date
-3.03%
1 Year
+30.57%
Key Figures
78.420Open
79.315High
364.29KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.96%Turnover Ratio
79.210Prev. Close
75.010Low
20.13MTurnover
LossP/E Static
3.94P/B
0.00%Div Yield TTM
-33.11%ROA
99.50052wk High
0.96Volume Ratio
-109.36MNet Profit
37.89MShares
-6.6386EPS TTM
0.93Beta
-35.83%ROE
40.00052wk Low
5.43%Amplitude
--Gross Margin
2.96BMarket Cap
0.92Reward/Risk
3.10%Risk Rate
Disc Medicine Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
13
analysts
Buy
Current Rating
101.000
Target Price
+37.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Disc Medicine Inc
IRON
13
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
75.828
Buy
MA10
75.340
Buy
MA20
76.119
Buy
MA50
72.477
Buy
MA100
69.092
Buy
MA200
74.771
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Disc Medicine Inc Info
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The Company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps), including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. It is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.
Ticker SymbolIRON
CompanyDisc Medicine Inc
CEOQuisel (John D)
Websitehttps://www.discmedicine.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Disc Medicine Inc (IRON)?
The current price of Disc Medicine Inc (IRON) is 77.00.
What is the symbol of Disc Medicine Inc?
The ticker symbol of Disc Medicine Inc is IRON.
What is the 52-week high of Disc Medicine Inc?
The 52-week high of Disc Medicine Inc is 99.50.
What is the 52-week low of Disc Medicine Inc?
The 52-week low of Disc Medicine Inc is 40.00.
What is the market capitalization of Disc Medicine Inc?
The market capitalization of Disc Medicine Inc is 2.92B.
Is Disc Medicine Inc (IRON) currently rated as Buy, Hold, or Sell?
According to analysts, Disc Medicine Inc (IRON) has an overall rating of Buy, with a price target of 101.00.
What is the Earnings Per Share (EPS TTM) of Disc Medicine Inc (IRON)?
The Earnings Per Share (EPS TTM) of Disc Medicine Inc (IRON) is -6.01.